Overview
Praxis Precision Medicines is a Boston-based biopharmaceutical company developing therapies for central nervous system disorders. It has no approved product; two new drug applications are under FDA review: relutrigine for SCN2A and SCN8A developmental and epileptic encephalopathies (PDUFA date December 27, 2026) and ulixacaltamide HCl for essential tremor (PDUFA date January 29, 2027). The company says commercial preparations and pre-launch activities are ongoing. Praxis reports one operating segment.
Hiring snapshot
Hiring by specialty
Open roles
Newest first, from Praxis Precision Medicines’s careers page.
- Account Specialist (Peachtree City, GA)Remote · Peachtree City, Georgia7d ago$160k–$192k
- Account Specialist (Macon, GA)Remote · Macon, Georgia7d ago$160k–$192k
- Account Specialist (Athens, GA)Remote · Athens, Georgia7d ago$160k–$192k
- Account Specialist (Toledo, OH)Remote · Toledo, Ohio8d ago$160k–$192k
- Account Specialist (Dayton, OH)Remote · Dayton, Ohio8d ago$160k–$192k
- Payer Engagement Lead - Regional AccountsRemote9d ago$214k–$234k
Divisions
Division information is pending company verification.Once Praxis Precision Medicines claims its page, you will see each division, who it calls on and how it pays.
Claim your pageMore from Praxis Precision Medicines
These sections fill in when Praxis Precision Medicines claims and verifies its page.